A Study to Assess if a Medicine Called Bamlanivimab is Safe and Effective in Reducing Hospitalization Due to COVID-19

NCT04796402 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

576

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

BIOLOGICAL: Bamlanivimab
OTHER: Standard of Care

Sponsor

Fraser Health

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]